Manohar Katakam

Manohar Katakam is the founder and CEO of SteroTherapeutics. Manohar has over 20 years of experience in the pharmaceutical and biotech industry, including senior management positions at Aventis Behring, Makindus, Onconova Therapeutics, and Pfizer.

Manohar has a proven track record in product development and commercialization, with a focus on rare diseases and formulation/compliance issues. Manohar has successfully negotiated contracts with CROs and CMOs, and has built strong relationships with key partners in the industry.

Under Manohar's leadership, SteroTherapeutics has developed a portfolio of products for rare diseases, as well as promising compounds that have the potential to meet unmet medical needs. The company is committed to providing innovative treatments to patients with rare disorders, and to making a positive impact on the lives of those affected by these conditions.

Manohar Katakam has a Ph.D. in Pharmaceutical Sciences from Auburn University, an M. Pharmacy in Pharmaceutics from Andhra University, and a B. Pharmacy from Kakatiya University.

Arthur Schwartz - SVP of Scientific Affairs, David Johnston - Chief Financial Officer, and Carroll Allen - SVP of Regulatory Affairs report to Manohar Katakam.